Could Pfizer and Merck Be Big Winners With COVID Pills?

Could Pfizer and Merck Be Big Winners With COVID Pills?

Source: 
Motley Fool
snippet: 
  • Pfizer and Merck are beginning phase 3 studies of their respective oral COVID-19 therapy candidates.
  • There could be a big market for COVID-19 pills over the next several years.